Bipolar Disorder Trial, Recruiting NCT07404085 Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07404085
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of bipolar disorder or recurring depression that is currently in partial or full remission (meaning symptoms are low or absent based on standardised rating scales)
  • People who either personally feel their memory or thinking has been affected, or who score below expected levels on a standardised cognitive (thinking and memory) test
  • People who are fluent in the Danish language

Who may not be able to join:

  • People who have a diagnosis of schizophrenia
  • People who have a neurological condition, including dementia
  • People who have dyslexia
  • People who have a serious physical illness
  • People who have kidney disease
  • People who have a heart or cardiovascular condition
  • People who have diabetes
  • People who have a current problem with alcohol or substance use
  • People who have had a severe head injury in the past
  • People who have a history of epilepsy
  • People who are currently pregnant or breastfeeding
  • People with a BMI over 30
  • People who weigh less than 45 kg
  • People who take certain sedative medications (benzodiazepines) above specified daily doses (confirm with trial site for exact amounts)
  • People with lithium levels in their blood above a certain threshold (confirm with trial site)
  • People who have had electroconvulsive therapy (ECT) within the two months before joining
  • People with high blood pressure above specified levels (confirm with trial site for exact thresholds)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kamilla Woznica Miskowiak, DMSc, DPhil, Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Phone: +4527134653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Registry
ClinicalTrials.gov
Start date
14 November 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Cognitive composite measure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov